BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipopolysaccharide
,
rs2230926
,
NEUROG3
,
Metabolism of xenobiotics
,
Obesity
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BW 10
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Fetal mammary glands of wild type and ER-alpha KO mice after BPA and EE2 exposure
Characterization of late-stage Drosophila grainy head IM-allele mutant embryos
Liver and cecum from mice exposed to aflatoxin B1 (AFB1) and/or Helicobacter hepaticus
Human Rhabdomyosarcoma biopsy samples
Explore Curated Studies Results
Literature
Most Relevant Literature
The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin r…
Boron exhibits hepatoprotective effect together with antioxidant, anti-inflammatory, and anti-apopto…
Effects of Substitution of Corn with Ground Brown Rice on Growth Performance, Nutrient Digestibility…
COVID-19 and Stressful Adjustment to Work: A Long-Term Prospective Study About Homeworking for Bank …
The impact of preconceptional exposure of F0 male mice to bisphenol A alone or in combination with X…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Moto…
Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (…
Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (AD…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ